TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SER

Serina Therapeutics Inc

Healthcare · Biotechnology

2.30$ +0.0% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SER
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
21.3% 78.8% 73.6% 54.5% 58.2% 70.8% 75.7% 85.0% 84.4% 87.5%
8.0% 76.6% 62.9% 31.6% 13.4% 18.5% 19.9% 85.0% 54.6% 44.0%
8.0% 76.6% 62.9% 31.6% 13.4% 18.5% 19.9% 85.0% 54.6% 44.0%
9.6% 1.1% 1.2% 4.9% 8.3% 0.8% 0.1% 0.6%
-51.0% -55.3%
15.6% 12.1%
28.9% 40.6% 27.6% 22.8% 6.8%
794.2% 13.6% 22.9% 64.8% 237.5% 476.5% 634.2% 460.1% 92.4% 100.5%
794.2% 13.6% 22.9% 44.3% 136.5% 284.3% 311.0% 15.8% 35.2% 51.3%
5.8% 61.0% 226.4% 235.9% 40.9% 2.9% 0.0%
8.1% 0.8% 1.4% 5.6% 19.4% 6.1% 17.5% 6.5% 11.1% 27.8%
49.9% 33.3% 0.0% 42.4%
-726.6% 75.6% 69.8% 29.8% -130.3% -375.1% -531.1% -360.1% 9.5% -0.5%
-1,860.8% -691.0% -694.0% -1,158.4% -2,473.2% -3,352.8% -3,585.6% -369.9% -659.1% -913.5%
31.6% 10.6% 9.3% 14.2% 27.3% 34.2% 33.3% 93.8% 109.4% 146.6%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?